LONDON,Jan. 25,2025-- Following the licensing agreement with X4 Pharmaceuticals,Norgine is pleased to see the announcement from X4 today that their Marketing Authorization Application (MAA) for mavor
Jan 26, 2025
SYDNEY,Jan. 24,2025-- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"),a clinical-stage radiopharmaceutical company with a mission to develop next-generation products t
Jan 26, 2025
HONG KONG,Jan. 24,2025-- Sino Group (the \'Group\'),the Ng Teng Fong Charitable Foundation (\'NTFCF\'),and the School of Chinese Medicine at Hong Kong Baptist University (\'HKBU\') are committed to th
Jan 26, 2025
SINGAPORE and PHILADELPHIA,Jan. 24,2025-- Nuevocor,an IND-stage biotechnology company dedicated to developing functional cures to treat cardiomyopathies with aberrant mechanobiology,today announces t
Jan 26, 2025
Shenzhen — The 12th China Entrepreneurship and Innovation Summit kicked off today in Shenzhen, bringing together a prominent cohort of tech leaders, entrepreneurs, and innovators. With 1,253 participants, including top executives, industry disruptors, and investors, the summit has established itself as a crucial platform for exchanging ideas and fostering collaboration. This year’s theme, "Global Synergies: Fostering Innovation for a New Era," underscores the event's emphasis on global cooperation and technological progress.
Jan 24, 2025
LONDON,Jan. 18,2025-- Kantar Group,a leading,global market research company based in London and portfolio company ofBain Capital,has announced today the proposed sale of Kantar Media to H.I.G. Capita
Jan 21, 2025
